US FDA deregulates medtech data systems to spur innovation in medical software
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued a final guideline stating that it does not intend to actively regulate products that are only used for electronically transferring, storing, displaying or converting medical device data from one format to another1,2.